Literature DB >> 418126

Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.

R L Perkins, R J Fass, J F Warner, R B Prior, T M File, R R Tight, W G Gardner, D E Ruiz, T G Slama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418126     DOI: 10.1093/infdis/137.supplement.s110

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

Review 1.  Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?

Authors:  R L Perkins
Journal:  Bull N Y Acad Med       Date:  1984-05

2.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

3.  Pharmacology, Safety, and efficacy of cefamandole in childhood infections.

Authors:  M C Thirumoorthi; A S Dajani; C V Vincent; M J Maurer
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

4.  Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

Authors:  D G Beckwith; J A Jahre
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

5.  Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins.

Authors:  D L Dworzack; M P Pugsley; C C Sanders; E A Horowitz
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

6.  Clinical evaluation of moxalactam.

Authors:  W K Livingston; A M Elliott; W E Dismukes; C K Avent; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

7.  Moxalactam therapy for a wide spectrum of bacterial infections in adults.

Authors:  R W Tofte; J Rotschafer; J Solliday; K B Crossley
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.